Roche presents new data for Polivy in previously untreated diffuse large B-cell lymphoma at ASH 2022
Patients receiving Polivy plus R-CHP for DLBCL reported similar health-related quality of life outcomes
Patients receiving Polivy plus R-CHP for DLBCL reported similar health-related quality of life outcomes
The Institute will focus on increasing preparedness and laboratory capabilities for identification of novel and unknown zoonotic agents
The two-day event focused on the multi-faceted relationship of clinical research stakeholders and looked at bridging the academic and clinical research gap.
Tambe has been with Biocon since 1997 and has held diverse leadership and operational roles.
Results showed a statistically significant and clinically meaningful improvement in investigator-assessed progression-free survival
The only definitive way to diagnose and stage lung cancers is through biopsies
The new production line is equipped with the latest advanced manufacturing system to produce quality products of Alkaloids & APIs used in a wide range of pharmaceutical applications
Omicron BA.5 continues to be the most prevalent sublineage in the United States (nearly 30% of cases) at the time of publication of the data
Zydus becomes the only Indian oncology player to venture into prognosis and diagnosis along with treatment planning
Subscribe To Our Newsletter & Stay Updated